AREXVY™ RSVPreF3 antigen/AS01E/PF 120 mcg / 0.5 mL Injection 0.5 mL

Name: Respiratory Syncytial Virus Vaccine, Adjuvanted
Brand: AREXVY™

AREXVY, VL RESPIRATORY SYNCYTIAL VIRUS VACCINE 0.5ML (10/BX)

McKesson #

1234598

Manufacturer #

58160084811

Brand

AREXVY™

Manufacturer

Glaxo Smith Kline

Country of Origin

Unknown

Application

Respiratory Syncytial Virus Vaccine, Adjuvanted

Container Type

Single-Dose Vial

Dosage Form

Injection

Generic Drug Code

54118

Generic Drug Name

RSVPreF3 antigen/AS01E/PF

NDC Number

58160084811

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Storage Requirements

Requires Refrigeration

Strength

120 mcg / 0.5 mL

Type

Intramuscular

UNSPSC Code

51201600

User

Indicated for People 60 Years of Age and Older

Volume

0.5 mL

AREXVY™ (Respiratory Syncytial Virus Vaccine, Adjuvanted) suspension for intramuscular injection
AREXVY™ is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in individuals 60 years of age and older